MorphoSys AG
Anti-CD19 antibody formulations
Last updated:
Abstract:
The present disclosure describes a pharmaceutical formulation of an anti-CD19 antibody.
Status:
Grant
Type:
Utility
Filling date:
27 Jun 2017
Issue date:
7 Jun 2022